Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy

  1. Quach, H.
  2. Nooka, A.
  3. Samoylova, O.
  4. Venner, C.P.
  5. Kim, K.
  6. Facon, T.
  7. Spencer, A.
  8. Usmani, S.Z.
  9. Grosicki, S.
  10. Suzuki, K.
  11. Delimpasi, S.
  12. Weisel, K.
  13. Obreja, M.
  14. Zahlten-Kumeli, A.
  15. Mateos, M.-V.
Aldizkaria:
British Journal of Haematology

ISSN: 1365-2141,  0007-1048

Argitalpen urtea: 2021

Alea: 194

Zenbakia: 4

Orrialdeak: 784-788

Mota: Gutuna

DOI: 10.1111/BJH.17541 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus